In its December meeting, the Board of the Einstein Foundation Berlin approved new research projects with a total funding of 13 million euros over the next six years.
Deadline: 13th February 2026
ProBioGen announced today the signing of a Master Service Agreement ("MSA") with Zag Bio, Inc., a biotechnology company developing thymus-targeted therapies to induce central immune tolerance.
Surprisingly, unmodified mRNA does not trigger an inflammatory response in T cells
Deadline: Februrary 1st 2026
Karen Christman, a Stiftung Charité Visiting Fellow at the Max Delbrück Center, is among the first researchers to have won a Humboldt Research Award under Germany’s Global Minds Initiative. The award will enable her to expand her research in Germany…
The Max Delbrück Center has recently completed construction of a new Demonstrator Lab as a testbed to reduce the environmental impact of biomedical research. The insights gained will be applied to all new building renovations across the center.
A team of researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center has captured the fleeting moment a nerve cell releases its neurotransmitters into the synaptic cleft. Their microscopic images and description of the process…
Neurons in the cerebral cortex form subtypes that differ in function and connectivity
Take your chance to pitch at the 𝗙𝗲𝗺𝗮𝗹𝗲𝗖𝗮𝗽𝗶𝘁𝗮𝗹 𝗽𝗶𝘁𝗰𝗵 𝗲𝘃𝗲𝗻𝘁 on 𝗝𝗮𝗻𝘂𝗮𝗿𝘆 𝟮𝟬, 𝟮𝟬𝟮𝟲 in 𝗕𝗲𝗿𝗹𝗶𝗻 – directly in front of a room full of women investors and those who aspire to become one.
